ID   FACD2_RAT               Reviewed;        1451 AA.
AC   Q6IV68;
DT   07-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2005, sequence version 2.
DT   24-JAN-2024, entry version 111.
DE   RecName: Full=Fanconi anemia group D2 protein homolog;
DE            Short=Protein FACD2;
GN   Name=Fancd2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar Kyoto; TISSUE=Liver;
RA   Rosemann M.F., Ivashkevich A., Lichtmannegger J.;
RT   "Strain specific allelic variations in the rat FanCD2 coding sequence.";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Required for maintenance of chromosomal stability. Promotes
CC       accurate and efficient pairing of homologs during meiosis. Involved in
CC       the repair of DNA double-strand breaks, both by homologous
CC       recombination and single-strand annealing. May participate in S phase
CC       and G2 phase checkpoint activation upon DNA damage. Plays a role in
CC       preventing breakage and loss of missegregating chromatin at the end of
CC       cell division, particularly after replication stress (By similarity).
CC       Promotes BRCA2/FANCD1 loading onto damaged chromatin. May also be
CC       involved in B-cell immunoglobulin isotype switching (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts directly with FANCE and FANCI. Interacts with USP1
CC       and MEN1. The ubiquitinated form specifically interacts with BRCA1 and
CC       BLM. Both the nonubiquitinated and the monoubiquitinated forms interact
CC       with BRCA2; this interaction is mediated by phosphorylated FANCG and
CC       the complex also includes XCCR3. The ubiquitinated form specifically
CC       interacts with MTMR15/FAN1 (via UBZ-type zinc finger), leading to
CC       recruit MTMR15/FAN1 to sites of DNA damage. Interacts with
CC       DCLRE1B/Apollo. Interacts with POLN. Interacts with UHRF1 and UHRF2;
CC       these interactions promote FANCD2 activation.
CC       {ECO:0000250|UniProtKB:Q9BXW9}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Note=Concentrates in
CC       nuclear foci during S phase and upon genotoxic stress. {ECO:0000250}.
CC   -!- PTM: Monoubiquitinated on Lys-561 during S phase and upon genotoxic
CC       stress by FANCL in complex with E2 ligases UBE2T or UBE2W.
CC       Deubiquitinated by USP1 as cells enter G2/M, or once DNA repair is
CC       completed. Monoubiquitination requires the joint intervention of the
CC       FANC core complex, including FANCA, FANCB, FANCC, FANCE, FANCF, FANCG,
CC       and FANCM, and proteins involved in cell cycle checkpoints and DNA
CC       repair, including RPA1, ATR, CHEK1 and BRCA1, and is mediated by
CC       FANCL/PHF9. Ubiquitination is required for binding to chromatin,
CC       interaction with BRCA1, BRCA2 and MTMR15/FAN1, DNA repair, and normal
CC       cell cycle progression (By similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated on several sites including Ser-222 and Ser-1401 in
CC       response to genotoxic stress. {ECO:0000250}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAT40425.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY621075; AAT40425.1; ALT_INIT; mRNA.
DR   RefSeq; NP_001001719.1; NM_001001719.1.
DR   AlphaFoldDB; Q6IV68; -.
DR   SMR; Q6IV68; -.
DR   STRING; 10116.ENSRNOP00000073556; -.
DR   PhosphoSitePlus; Q6IV68; -.
DR   PaxDb; 10116-ENSRNOP00000033638; -.
DR   GeneID; 312641; -.
DR   KEGG; rno:312641; -.
DR   UCSC; RGD:1303172; rat.
DR   AGR; RGD:1303172; -.
DR   CTD; 2177; -.
DR   RGD; 1303172; Fancd2.
DR   eggNOG; KOG4712; Eukaryota.
DR   InParanoid; Q6IV68; -.
DR   OrthoDB; 8542at2759; -.
DR   PhylomeDB; Q6IV68; -.
DR   TreeFam; TF101106; -.
DR   Reactome; R-RNO-6783310; Fanconi Anemia Pathway.
DR   PRO; PR:Q6IV68; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0000793; C:condensed chromosome; ISO:RGD.
DR   GO; GO:1990391; C:DNA repair complex; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0070182; F:DNA polymerase binding; ISO:RGD.
DR   GO; GO:0048854; P:brain morphogenesis; ISO:RGD.
DR   GO; GO:0034599; P:cellular response to oxidative stress; ISO:RGD.
DR   GO; GO:0006974; P:DNA damage response; ISO:RGD.
DR   GO; GO:1990918; P:double-strand break repair involved in meiotic recombination; IBA:GO_Central.
DR   GO; GO:0007276; P:gamete generation; ISO:RGD.
DR   GO; GO:0007129; P:homologous chromosome pairing at meiosis; ISO:RGD.
DR   GO; GO:0036297; P:interstrand cross-link repair; IBA:GO_Central.
DR   GO; GO:0031573; P:mitotic intra-S DNA damage checkpoint signaling; IBA:GO_Central.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; ISO:RGD.
DR   GO; GO:2000348; P:regulation of CD40 signaling pathway; ISO:RGD.
DR   GO; GO:0050727; P:regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0045589; P:regulation of regulatory T cell differentiation; ISO:RGD.
DR   GO; GO:0010332; P:response to gamma radiation; ISO:RGD.
DR   CDD; cd11721; FANCD2; 1.
DR   InterPro; IPR029448; FANCD2.
DR   PANTHER; PTHR32086; FANCONI ANEMIA GROUP D2 PROTEIN; 1.
DR   PANTHER; PTHR32086:SF0; FANCONI ANEMIA GROUP D2 PROTEIN; 1.
DR   Pfam; PF14631; FancD2; 1.
PE   2: Evidence at transcript level;
KW   Cell cycle; DNA damage; DNA repair; Isopeptide bond; Nucleus;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   CHAIN           1..1451
FT                   /note="Fanconi anemia group D2 protein homolog"
FT                   /id="PRO_0000087170"
FT   REGION          1..291
FT                   /note="Interaction with FANCE"
FT                   /evidence="ECO:0000250"
FT   REGION          248..359
FT                   /note="Interaction with BRCA2"
FT                   /evidence="ECO:0000250"
FT   REGION          858..879
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1399..1451
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1399..1421
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1433..1451
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         222
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BXW9"
FT   MOD_RES         716
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BXW9"
FT   MOD_RES         1257
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BXW9"
FT   MOD_RES         1406
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BXW9"
FT   MOD_RES         1414
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BXW9"
FT   CROSSLNK        561
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BXW9"
SQ   SEQUENCE   1451 AA;  163621 MW;  5FE7FC72DA46834D CRC64;
     MVSKRSRLDF EDKETLAEDA SKIMKQPLSK LAKKSCGSHE VEENGSVFVR LLKASGLTLK
     TGDNQNQLGV DQIIFQRKLF QALRKHPSYP KVIEEFVNGL ESYTEDIDSL RNCLLSCERL
     QDEEASMGTF YSKSLIKLLL GIDILQPAII KMLFEKVPQF LFESESRDGI SMPRLIISQL
     KWLDRIVDSK DLTTQMMQLI SVAPVNLQHD FITSLPEILG DSQHANVGKE LSELLVQNTS
     LTVPILDVFS SLRLDPNFLS EIRQLVMGKL SSVRLEDLPV IVKFILHSVT DSTSLEVIAE
     LREKLNVQHF TLPSRIQASQ SKLKSKGLAS SSGNQENSDK DCIVLLFDVI KSAIRYEKTI
     SEAWIKAIER IQSAAEHKAL DVAMLLIIYG TSTQTKKGVE RLLRNKIQSD CIQEQLLDST
     FSTHCLVLKD ICPSILLLAQ TLFHSQDQRI ILFGSLLCKY AFKFFDTYCQ QEVVGALVTH
     VCSGNEAEVD AALDVLLELI VLNASAMRLN AAFIKGILDY LENMSPQQIR KIFCILSTLA
     FSQQPGTSNH IQDDMHLVIR KQLSSTVFKY KLIGIIGAVT MAGIMAEDRT MPSNSTQRSA
     SVSSEQHTQV TSLLQLVHSC TEHSPWASSL YYDEFANLIQ ERKLAPKTLE WVAQTIFNDF
     QDAFVVDFCA VPEGDFPFPV KALYGLEECN TQDGIVINLL PLFFQEFAKD VSQVTSQESS
     QKSMSPLCLA SHFRLLRLCV ARQHNGNLDE IDALLDCPLF LPDLEPGEKL ESMSAKDRSL
     MCSLTFLTFN WFREVVNAFC QQTSPEMKGK VLSRLKDLVE LQEILEKYLA VIPDYVPPFT
     SVDLDTLDVI PRSNSAVAAK SRHKGKTGGK KQKADSSTAS CTDTLLTEDT SECDVAPSGK
     SQVDKESTGK EGKTFVSLQN YRAFFRELDI EVFSILHSGL VTKFILDTEM HTEATEVVQL
     GPAELLFLLE DLSQKLENRL TPSFTKRVCF FKNKGSRNIG FSHLHQRSVQ DIVHCVVQLL
     TPMCNHLENI HNFFQCLGAE NLSVNDKARV TAQEHYTMSS CYQKLLQVFH ALLAWKGFTH
     QSNHRLLRSA LEVLASRLKQ TEEGQPLEEL LSQSFSYLQN LQHSIPSFQC GLYLLRLLMA
     LLEKSAVPTQ KKEKLASLAK QLLCRAWPHG DKEKNPTFND HLHDLLCIYL EHTDNVLKAI
     EEITGVGVPE LVNAPKDASS STFPTLTRHT FVIFFRVMMA ELEKTVKGLQ AGTATDSQQV
     HEEKLLYWNM AVRDFSILIN LMKVFDSYPV LHVCLKYGRR FVEAFLKQCM PLLDFSFRKH
     RDDVLSLLQT LQLNTRLLHH LCGHSKIHQD TRLTKHVPLL KKSLELLVCR VKAMLVLNNC
     REAFWLGTLK NRDLQGEEII SQHPSSPENT SEDSEDGMTS YVSRNRAIED GEDEANDGQD
     RDSDESDDSS S
//
